XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.85−0.11 (-5.61%)
Close on Nov 16, 2026Market cap $56.40MP/E –Yield –
XBiotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
XBiotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.70M. For fiscal 2025 it was -$39.92M. The highest annual figure on record is $69.45M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$39.92M | – |
| FY2024 | Dec 31, 2024 | -$30.96M | – |
| FY2023 | Dec 31, 2023 | -$18.73M | – |
| FY2022 | Dec 31, 2022 | -$14.82M | -121.3% |
| FY2021 | Dec 31, 2021 | $69.45M | – |
| FY2020 | Dec 31, 2020 | -$65.15M | – |
| FY2019 | Dec 31, 2019 | -$18.27M | – |
| FY2018 | Dec 31, 2018 | -$16.54M | – |
| FY2017 | Dec 31, 2017 | -$33.65M | – |
| FY2016 | Dec 31, 2016 | -$46.02M | – |
| FY2015 | Dec 31, 2015 | -$33.31M | – |
| FY2014 | Dec 31, 2014 | -$11.70M | – |
| FY2013 | Dec 31, 2013 | -$8.91M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.52M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.95M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.26M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.72M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.20M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.43M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.00M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.39M | -107.4% |
| Q1 FY2022 | Mar 31, 2022 | -$5.12M | -383.2% |
| Q4 FY2021 | Dec 31, 2021 | -$1.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.40M | -145.5% |
| Q2 FY2021 | Jun 30, 2021 | $72.80M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$391.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $7.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$11.57M | – |
| Q1 FY2020 | Mar 31, 2020 | -$60.67M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.98M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.86M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.00M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.90M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.53M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.47M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.47M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.91M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.80M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.02M | – |
See a number that looks wrong?